Mediators of Inflammation / 2019 / Article / Fig 4

Research Article

Isorhamnetin Inhibits Liver Fibrosis by Reducing Autophagy and Inhibiting Extracellular Matrix Formation via the TGF-β1/Smad3 and TGF-β1/p38 MAPK Pathways

Figure 4

IH attenuated ECM accumulation in livers. (a) qPCR was used to determine the mRNA expression of PPAR-γ, α-SMA, Col-1α1, Col-1α2, MMP-2, and TIMP1 in liver tissues. Results are given as fold change over the control (vehicle or sham) group. (b) Western blotting was used to detect the protein expression of PPAR-γ, α-SMA, Col-1, MMP-2, and TIMP1 in liver tissues in mice of each group. (c) Immunohistochemical staining was performed to analyze the expression of α-SMA and Col-1 in liver sections (brown indicates positive staining, original magnification: ×200, scale bar: 100 μm). Data are presented as (, compared to the vehicle (sham) group, compared to the CCl4 (BDL) group, and compared to the CCl4 (BDL)+IH 10 mg/kg group).
(a)
(b)
(c)

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.